IL133709A0 - Device for optimized electrotransfer of nucleic acid vectors to tissues in vivo - Google Patents

Device for optimized electrotransfer of nucleic acid vectors to tissues in vivo

Info

Publication number
IL133709A0
IL133709A0 IL13370998A IL13370998A IL133709A0 IL 133709 A0 IL133709 A0 IL 133709A0 IL 13370998 A IL13370998 A IL 13370998A IL 13370998 A IL13370998 A IL 13370998A IL 133709 A0 IL133709 A0 IL 133709A0
Authority
IL
Israel
Prior art keywords
electrotransfer
tissues
vivo
optimized
nucleic acid
Prior art date
Application number
IL13370998A
Original Assignee
Rhone Poulence Rorer S A
Roussy Inst Gustave
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9708233A external-priority patent/FR2765242B1/en
Priority claimed from FR9708232A external-priority patent/FR2765241B1/en
Application filed by Rhone Poulence Rorer S A, Roussy Inst Gustave, Centre Nat Rech Scient filed Critical Rhone Poulence Rorer S A
Publication of IL133709A0 publication Critical patent/IL133709A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/325—Applying electric currents by contact electrodes alternating or intermittent currents for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL13370998A 1997-06-30 1998-06-30 Device for optimized electrotransfer of nucleic acid vectors to tissues in vivo IL133709A0 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
FR9708233A FR2765242B1 (en) 1997-06-30 1997-06-30 IMPROVEMENT OF THE TRANSFER OF NUCLEIC ACID IN THE STRIKE MUSCLE AND COMBINATION ALLOWING THE IMPLEMENTATION OF THE PROCESS
FR9708232A FR2765241B1 (en) 1997-06-30 1997-06-30 IMPROVEMENT OF NUCLEIC ACID TRANSFER IN CELLS OF PLURICELLULAR EUKARYOTIC ORGANISMS AND COMBINATION FOR CARRYING OUT THE METHOD
US6748797P 1997-12-01 1997-12-01
US6748897P 1997-12-01 1997-12-01
US8385898P 1998-05-01 1998-05-01
PCT/EP1998/003976 WO1999001175A1 (en) 1997-06-30 1998-06-30 Device for optimized electrotransfer of nucleic acid vectors to tissues in vivo

Publications (1)

Publication Number Publication Date
IL133709A0 true IL133709A0 (en) 2001-04-30

Family

ID=27515625

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13370998A IL133709A0 (en) 1997-06-30 1998-06-30 Device for optimized electrotransfer of nucleic acid vectors to tissues in vivo

Country Status (11)

Country Link
EP (1) EP0993318A1 (en)
JP (1) JP2002515816A (en)
KR (1) KR20010014298A (en)
CN (1) CN1261812A (en)
AU (1) AU8730798A (en)
BR (1) BR9810500A (en)
CA (1) CA2295029A1 (en)
IL (1) IL133709A0 (en)
NO (1) NO996540L (en)
PL (1) PL337617A1 (en)
WO (1) WO1999001175A1 (en)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2753379B1 (en) 1996-09-13 1998-10-30 Rhone Poulenc Rorer Sa METHOD OF TREATING AMYOTROPHIC SIDE SCLEROSIS
US6261281B1 (en) * 1997-04-03 2001-07-17 Electrofect As Method for genetic immunization and introduction of molecules into skeletal muscle and immune cells
CA2361601A1 (en) * 1999-02-08 2000-08-10 Cheryl Goldbeck Electrically-mediated enhancement of dna vaccine immunity and efficacy in vivo
ES2368419T3 (en) 2000-03-13 2011-11-17 Cornell Research Foundation, Inc. BLOCK OF MIGRATION OF LEUCOCITS AND INFLAMMATION BY INTERFERENCE WITH CD99 / HEC2.
US7416726B2 (en) 2000-04-13 2008-08-26 The Rockefeller University Enhancement of antibody-mediated immune responses
EP1292359A4 (en) 2000-05-22 2005-03-30 Merck & Co Inc System and method for assessing the performance of a pharmaceutical agent delivery system
ATE501161T1 (en) 2000-12-28 2011-03-15 Wyeth Llc RECOMBINANT PROTECTIVE PROTEIN FROM STREPTOCOCCUS PNEUMONIAE
DK1499349T3 (en) 2001-03-02 2010-04-06 Univ Rockefeller Recombinant Hybrid Allergen Hybrid Allergen Constructs That Maintain Immunogenic Allergy Immunogenicity
US20020198567A1 (en) * 2001-06-07 2002-12-26 Yona Keisari Electro-endocytotic therapy as a treatment modality of cancer
MX339524B (en) 2001-10-11 2016-05-30 Wyeth Corp Novel immunogenic compositions for the prevention and treatment of meningococcal disease.
JP2005518904A (en) 2002-03-07 2005-06-30 マーク アンド カンパニー インコーポレイテッド Clinical syringe with electrical stimulation aspect
KR101086533B1 (en) 2002-05-24 2011-11-23 쉐링 코포레이션 Neutralizing human anti-IGFR antibody, a method for producing it and a composition comprising it
US7785608B2 (en) 2002-08-30 2010-08-31 Wyeth Holdings Corporation Immunogenic compositions for the prevention and treatment of meningococcal disease
EP1759714A1 (en) * 2005-09-02 2007-03-07 Bioalliance Pharma Electrotransfer of nucleic acid into tissue cells
EP3804809B1 (en) * 2005-10-03 2023-12-27 Novocure GmbH Optimizing characteristics of an electric field to increase the field's effect on proliferating cells
JP4961137B2 (en) * 2005-12-14 2012-06-27 久光製薬株式会社 Device for iontophoresis
PL2068921T3 (en) 2006-10-19 2014-12-31 Csl Ltd High affinity antibody antagonists of interleukin-13 receptor alpha 1
EP2068922B1 (en) 2006-10-19 2012-06-27 CSL Limited Anti-il-13r alpha 1 antibodies and their uses thereof
AR064642A1 (en) 2006-12-22 2009-04-15 Wyeth Corp POLINUCLEOTIDE VECTOR THAT INCLUDES IT RECOMBINATING CELL THAT UNDERSTANDS THE VECTOR POLYPEPTIDE, ANTIBODY, COMPOSITION THAT UNDERSTANDS THE POLINUCLEOTIDE, VECTOR, RECOMBINATING CELL POLYPEPTIDE OR ANTIBODY, USE OF THE COMPOSITION AND A COMPOSITION AND A METHOD
US8246176B2 (en) 2007-03-06 2012-08-21 Sanyo Electric Co., Ltd. Projection display device having an operation section for displacing a lens
US8093043B2 (en) 2008-06-04 2012-01-10 New York University β-TrCP1, β-TrCP2 and RSK1 or RSK2 inhibitors and methods for sensitizing target cells to apoptosis
EP2310500B1 (en) * 2008-07-18 2015-03-11 Maxcyte, Inc. Methods for optimizing electroporation
AR074273A1 (en) 2008-11-05 2011-01-05 Wyeth Corp IMMUNE COMPOSITION OF MULTIPLE COMPONENTS FOR THE PREVENTION OF BETA-HEMOLITIC BHS STREPTOCOCITIC DISEASE. USE. METHOD
RU2580620C2 (en) 2010-08-23 2016-04-10 ВАЙЕТ ЭлЭлСи STABLE COMPOSITIONS OF ANTIGENS Neisseria meningitidis rLP2086
PE20140173A1 (en) 2010-09-10 2014-02-20 Wyeth Llc NON-LIPIDED VARIANTS OF NEISSERIA MENINGITIDIS ANTIGENS ORF2086
SA115360586B1 (en) 2012-03-09 2017-04-12 فايزر انك Neisseria meningitidis compositions and methods thereof
MY198910A (en) 2012-03-09 2023-10-02 Pfizer Neisseria meningitidis compositions and methods thereof
WO2014107739A1 (en) 2013-01-07 2014-07-10 Eleven Biotherapeutics, Inc. Antibodies against pcsk9
EP2964665B1 (en) 2013-03-08 2018-08-01 Pfizer Inc Immunogenic fusion polypeptides
MX369534B (en) 2013-09-08 2019-11-11 Pfizer Neisseria meningitidis compositions and methods thereof.
CN107249626A (en) 2015-02-19 2017-10-13 辉瑞大药厂 Neisseria meningitidis composition and its method
SG11201906519RA (en) 2017-01-31 2019-08-27 Pfizer Neisseria meningitidis compositions and methods thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9317380D0 (en) * 1993-08-20 1993-10-06 Therexsys Ltd Transfection process
US5641680A (en) * 1994-11-14 1997-06-24 Zhao; Xi Gene transfer apparatus and method for using the same
AU6855796A (en) * 1995-08-29 1997-03-19 Cbr Laboratories, Inc. In vivo electroporation of cells

Also Published As

Publication number Publication date
CN1261812A (en) 2000-08-02
NO996540D0 (en) 1999-12-29
JP2002515816A (en) 2002-05-28
BR9810500A (en) 2000-09-05
KR20010014298A (en) 2001-02-26
CA2295029A1 (en) 1999-01-14
NO996540L (en) 2000-02-03
WO1999001175A1 (en) 1999-01-14
PL337617A1 (en) 2000-08-28
EP0993318A1 (en) 2000-04-19
AU8730798A (en) 1999-01-25

Similar Documents

Publication Publication Date Title
IL133709A0 (en) Device for optimized electrotransfer of nucleic acid vectors to tissues in vivo
HUP0001261A3 (en) Method of imaging cell death in vivo
GB2331247B (en) Improvements in relation to apparatus for surgical diathermy
GB9713077D0 (en) Improvements relating to skin prickers
IL134842A0 (en) Method of delivering genes to antigen presenting cells of the skin
PL316200A1 (en) Co-ordinated expression of genes in vivo
EP0779935A4 (en) Detection of hypermutable nucleic acid sequence in tissue
GB9624165D0 (en) Use of nucleic acids bound to carrier macromolecules
PL325821A1 (en) Liquid acid netralising preparation
PL337942A1 (en) Isolated genes of dendricall cell membranic proteins
GB9708512D0 (en) Improvements relating to skin prickers
ZA986003B (en) Compositions and methods for enhancing delivery of therapeutic agents to cells
GB2346841B (en) Advantageous use of battery mass in electric watercraft
GB9515356D0 (en) Improvements in or relating to delivery of nucleic acid
GB9717932D0 (en) Estimation of nucleic acid
IL149506A0 (en) Human heparanase-related polypeptide and nucleic acid
GB9718320D0 (en) Improvements in or relating to gel loading
GB9705007D0 (en) Improvements in or relating to therapeutic genes
GB2369500B (en) Terminal unit in which waterproof effect is improved
TW444691U (en) Improved structure of car power connector
IL120714A0 (en) Continuous in vitro evolution of oligonucleotides
GB9928530D0 (en) Constructs for delivery of therapeutic agents to neuronal cells
GB9711839D0 (en) Improvements in or relating to diagnostic/therapeutic agents
GB9711845D0 (en) Improvements in or relating to diagnostic/therapeutic agents
GB9711844D0 (en) Improvements in or relating to diagnostic/therapeutic agents